Analystreport

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) had its "sell" rating re-affirmed by analysts at UBS Group AG. They now have a $33.00 price target on the stock.

Ionis Pharmaceuticals, Inc.  (IONS) 
Last ionis pharmaceuticals, inc. earnings: 2/26 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ionispharma.com